Post-transplant diabetes mellitus (PTDM) is a frequent consequence of solid organ
transplantation. PTDM has been associated with greater mortality and increased infections …

Although advances in immunosuppression, tissue typing, surgery, and medical
management have made transplantation a routine and preferred treatment for patients with …

Introduction: Despite major advances in kidney transplant, glucocorticoids (GCs) or steroids
remain one of the mainstay treatments. They possess adverse events (AEs) that are related …

Uterine transplantation (UTx) is a fertility restoring treatment for women with absolute uterine
factor infertility. At a time when there is no question of the procedure's feasibility, and as the …

The aim of this study was to investigate the prevalence and associated factors of
glucocorticoid-induced diabetes mellitus (GDM) in patients with systemic lupus …

Abstract New-Onset Diabetes After Transplantation (NODAT) is an increasingly recognized
severe metabolic complication of kidney transplantation causing lower graft function and …

Calcineurin inhibitors like FK506 (tacrolimus) are routinely used for immunosuppression
following transplantation. Its use is limited by many side effects, including renal tubular …

Renal transplantation has important benefits in people with end‐stage renal disease, with
improvements in mortality, morbidity and quality of life. Whilst significant advances in …

Background. Post-transplant diabetes mellitus (PTDM) has serious consequences for renal
allograft survival, cardiovascular risk and patient survival. Methods. The predictive value of a …

Introduction: New-onset diabetes after transplantation (NODAT) is an increasingly
recognised metabolic complication of kidney transplantation that is associated with …